Communiqués Nunzia Pharmaceutical Company

Actions

NUNZ

US67097W1027

Produits pharmaceutiques

Marché Fermé - OTC Markets 15:31:22 21/01/2026			Varia. 5j.	Varia. 1 janv.
0,000100 ^USD	-.--%		-.--%	-

14/11/22	Nunzia Pharmaceutical Company annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2022	CI
03/10/22	Nunzia Pharmaceutical Company annonce ses résultats pour le deuxième trimestre et les six mois terminés le 30 juin 2022	CI

Communiqués

14/11/22	NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
03/10/22	NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
23/05/22	NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
15/04/22	NUNZIA PHARMACEUTICAL CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
29/03/22	NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	AQ
28/03/22	Nunzia Pharmaceutical : Annual Report Late filing	PU
18/03/22	NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	AQ
02/03/22	NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	AQ
10/11/21	NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
16/09/21	NUNZIA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
16/09/21	NUNZIA PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
17/08/21	NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	AQ
16/08/21	Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Now Offering a Patented Blood Warmer Through Nunzia's Medical Supply Division. 8K Filed 08/05/2021	AQ
06/08/21	Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER	AQ
04/08/21	NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	AQ
07/05/21	NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
05/05/20	Nunzia Pharmaceutical Corporation, an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Proud to Start Studies on Anxiety-Based Tinnitus	GL
16/04/20	Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals	GL
14/04/20	Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals	GL
02/12/19	Nunzia Pharmaceutical : ARIZONA GOLD & ONYX MINING CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ